$40M Without Venture Funding
HDAC Firm Acetylon Adds $15M Equity Investment from Celgene
By Marie Powers
Friday, February 10, 2012
Privately held biotech Acetylon Pharmaceuticals Inc. continued its string of successful private investments with a $15 million equity stake by Celgene Corp.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.